Intramuscular glutathione as a systemic whitening agent
- Disease/Condition
- Skin and Connective Tissue Diseases
- Intervention type
- drug
- Primary sponsor
- Sohag University Hospital
- Funder
- Amr Abdelhamed
- Location
- Egypt
- Phase
- Not Applicable
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
Getting a lighter skin tone always draws a lot of interest, especially for women. Women in some cases, their marriage prospects or career opportunities are dominated by the hue of their skin. There are limited studies about the glutathione as a systemic withering agent. The intravenous Glutathione is limited in use because of complications and the oral form is less effected. Therefore, we conduct this trial to demonstrate the efficacy and safety of IM glutathione as a systemic whitening agent.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR201907742980888
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR201907742980888 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sohag University Hospital and is currently Not yet recruiting. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.